Humira Email to Patients: How to improve the conversation with your doctor
Brand: Humira (adalimumab), Injection
Parent Company: Abbvie
Drug Type: Boxed Warning
Drug Category: Multiple Indications/Therapeutic Areas
Campaign: Post-Launch
Targeting: Patients
Patient Website: https://www.humira.com/
HCP Website: https://www.humirapro.com/